MichaelJosephJacksonMD

PubMed

• Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
  Lincoln L, Fisher R, Jackson MJ, Jenner P, Neumeyer J, Sromek AW, Lees AJ, Rose S> ;Mov. Disord.. 2016-09-01
• The H3 receptor agonist immepip does not affect l-dopa-induced abnormal involuntary movements in 6-OHDA-lesioned rats.
  Papathanou M, Jenner P, Iravani M, Jackson M, Stockwell K, Strang I, Zeng B, McCreary AC, Rose S> ;Eur. J. Pharmacol.. 2014-10-15
• Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
  Tayarani-Binazir, K.A., Jackson, M.J., Strang, I., Jairaj, M., Rose, S., Jenner, P., Chou, Y.P.> ;Behav Pharmacol. 2012 Apr
• Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
  Zeng, B., Iravani, M.M., Jackson, M.J., Rose, S., Parent, A., Jenner, P.> ;Neurobiol Dis. 2010 Dec
• Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets.
  Johnston, L.C., Jackson, M.J., Rose, S., McCreary, A.C., Jenner, P.> ;Mov Disord. 2010 Oct 15
• An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy...
  Jones CA, Johnston LC, Jackson MJ, Smith LA, van Scharrenburg G, Rose S, Jenner PG, McCreary AC> ;Eur Neuropsychopharmacol. 2010-08-01
• The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated ...
  Tayarani-Binazir KA, Jackson MJ, Fisher R, Zoubiane G, Rose S, Jenner P> ;Eur. J. Pharmacol.. 2010-06-10
• Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.
  Tayarani-Binazir, K.A., Jackson, M.J., Rose, S., Olanow, C.W., Jenner, P.> ;Mov Disord. 2010 Feb 15
• Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.
  Stockwell KA, Scheller D, Rose S, Jackson MJ, Tayarani-Binazir K, Iravani MM, Smith LA, Olanow CW, Jenner P> ;Exp. Neurol.. 2009-10-01
• The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates.
  Zubair, M., Jackson, M.J., Tayarani-Binazir, K., Stockwell, K.A., Smith, L.A., Rose, S., Olanow, W., Jenner, P.> ;Exp Neurol. 2007 Dec
• Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
  Katzenschlager, R., Jackson, M.J., Rose, S., Stockwell, K., Tayarani-Binazir, K.A., Zubair, M., Smith, L.A., Jenner, P., Lees, A.J.> ;Mov Disord. 2007 Apr 15
• Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.
  Rose S, Scheller DKA, Breidenbach A, Smith L, Jackson M, Stockwell K, Jenner P> ;Behav Pharmacol. 2007-03-01
• Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.
  Jackson, M.J., Smith, L.A., Al-Barghouthy, G., Rose, S., Jenner, P.> ;Exp Neurol. 2007 Mar
• In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia bu...
  Iravani, M.M., Tayarani-Binazir, K., Chu, W.B., Jackson, M.J., Jenner, P.> ;J Pharmacol Exp Ther. 2006 Dec
• The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
  Rose S, Jackson MJ, Smith LA, Stockwell K, Johnson L, Carminati P, Jenner P> ;Eur. J. Pharmacol.. 2006-09-28
• TBT causes regime shift in shallow lakes.
  Sayer, C.D., Hoare, D.J., Simpson, G.L., Henderson, A.G., Liptrot, E.R., Jackson, M.J., Appleby, P.G., Boyle, J.F., Jones, I.I., Waldock, M.J.> ;Environ Sci Technol. 2006 Sep 1
• Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-tre...
  Smith, L.A., Jackson, M.J., Johnston, L., Kuoppamaki, M., Rose, S., Al-Barghouthy, G., Del Signore, S., Jenner, P.> ;Clin Neuropharmacol. 2006-05-01
• Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets.
  Hurley MJ, Jackson MJ, Smith LA, Rose S, Jenner P> ;Eur. J. Neurosci.. 2005-06-01
• Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
  Smith, L. A.,Jackson, M. J.,Al-Barghouthy, G.,Rose, S.,Kuoppamaki, M.,Olanow, W.,Jenner, P.> ;Mov Disord. 2005 Mar
• A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.
  Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P> ;Eur. J. Neurosci.. 2005-02-01
• Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets.
  Jackson, M.J., Al-Barghouthy, G., Pearce, R.B., Smith, L., Hagan, J.J., Jenner, P.> ;Pharmacol Biochem Behav. 2004 Nov
• The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
  Hansard, M.J., Smith, L.A., Jackson, M.J., Cheetham, S.C., Jenner, P.> ;Mov Disord. 2004 Jan
• 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
  Iravani, M. M., Jackson, M. J., Kuoppamäki, M., Smith, L. A., Jenner, P.> ;J Neurosci. 2003 Oct 8
• Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administr...
  Smith, L.A., Jackson, M.J., Hansard, M.J., Maratos, E., Jenner, P.> ;Mov Disord. 2003 May
• Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).
  Maratos, E.C., Jackson, M.J., Pearce, R.B., Cannizzaro, C., Jenner, P.> ;Exp Neurol. 2003 Jan
• Join now to see all